Karyotypically normal spontaneous premature ovarian failure: Evaluation of association with the class II major histocompatibility complex

J. N. Anasti, S. Adams, L. M. Kimzey, R. A. Defensor, A. A. Zachary, L. M. Nelson

Research output: Contribution to journalArticle

Abstract

Patients with premature ovarian failure (POF) have been reported to have an increased frequency of the major histocompatibility class (MHC) class II antigen HLA-DR3. Here we attempt to confirm this association. We performed MHC class II immunophenotyping of HLA-DR antigens 1-10 on 102 North American caucasians with confirmed POF and 102 control caucasian women. All patients had experienced amenorrhea before the age of 40 yr and had elevated serum gonadotropins on repeated study. We found no significant increase in HLA-DR3 frequency in patients with POF when compared to our control group (P = 0.52) or even when compared to a large reference population (n = 1927) that did not differ significantly from our control group (P = 0.47). Our patients did have an increased frequency of HLA DR4 compared to this large reference population (41% vs. 23%; P <0.001), but we were unable to demonstrate increased HLA DR4 frequency using our control group (31%; P = 0.14). In conclusion, despite a power of 99%, we were unable to confirm a significant increase in MHC class II HLA-DR3 frequency in patients with POF.

Original languageEnglish (US)
Pages (from-to)722-723
Number of pages2
JournalJournal of Clinical Endocrinology and Metabolism
Volume78
Issue number3
DOIs
StatePublished - Mar 1994
Externally publishedYes

Fingerprint

Primary Ovarian Insufficiency
HLA-DR3 Antigen
Major Histocompatibility Complex
Histocompatibility
HLA-DR4 Antigen
Control Groups
Histocompatibility Antigens Class II
HLA-DR Antigens
Immunophenotyping
Gonadotropins
Amenorrhea
Population
Serum

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Karyotypically normal spontaneous premature ovarian failure : Evaluation of association with the class II major histocompatibility complex. / Anasti, J. N.; Adams, S.; Kimzey, L. M.; Defensor, R. A.; Zachary, A. A.; Nelson, L. M.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 78, No. 3, 03.1994, p. 722-723.

Research output: Contribution to journalArticle

Anasti, J. N. ; Adams, S. ; Kimzey, L. M. ; Defensor, R. A. ; Zachary, A. A. ; Nelson, L. M. / Karyotypically normal spontaneous premature ovarian failure : Evaluation of association with the class II major histocompatibility complex. In: Journal of Clinical Endocrinology and Metabolism. 1994 ; Vol. 78, No. 3. pp. 722-723.
@article{335ef74a236d4bb7ac293d56898fa191,
title = "Karyotypically normal spontaneous premature ovarian failure: Evaluation of association with the class II major histocompatibility complex",
abstract = "Patients with premature ovarian failure (POF) have been reported to have an increased frequency of the major histocompatibility class (MHC) class II antigen HLA-DR3. Here we attempt to confirm this association. We performed MHC class II immunophenotyping of HLA-DR antigens 1-10 on 102 North American caucasians with confirmed POF and 102 control caucasian women. All patients had experienced amenorrhea before the age of 40 yr and had elevated serum gonadotropins on repeated study. We found no significant increase in HLA-DR3 frequency in patients with POF when compared to our control group (P = 0.52) or even when compared to a large reference population (n = 1927) that did not differ significantly from our control group (P = 0.47). Our patients did have an increased frequency of HLA DR4 compared to this large reference population (41{\%} vs. 23{\%}; P <0.001), but we were unable to demonstrate increased HLA DR4 frequency using our control group (31{\%}; P = 0.14). In conclusion, despite a power of 99{\%}, we were unable to confirm a significant increase in MHC class II HLA-DR3 frequency in patients with POF.",
author = "Anasti, {J. N.} and S. Adams and Kimzey, {L. M.} and Defensor, {R. A.} and Zachary, {A. A.} and Nelson, {L. M.}",
year = "1994",
month = "3",
doi = "10.1210/jc.78.3.722",
language = "English (US)",
volume = "78",
pages = "722--723",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Karyotypically normal spontaneous premature ovarian failure

T2 - Evaluation of association with the class II major histocompatibility complex

AU - Anasti, J. N.

AU - Adams, S.

AU - Kimzey, L. M.

AU - Defensor, R. A.

AU - Zachary, A. A.

AU - Nelson, L. M.

PY - 1994/3

Y1 - 1994/3

N2 - Patients with premature ovarian failure (POF) have been reported to have an increased frequency of the major histocompatibility class (MHC) class II antigen HLA-DR3. Here we attempt to confirm this association. We performed MHC class II immunophenotyping of HLA-DR antigens 1-10 on 102 North American caucasians with confirmed POF and 102 control caucasian women. All patients had experienced amenorrhea before the age of 40 yr and had elevated serum gonadotropins on repeated study. We found no significant increase in HLA-DR3 frequency in patients with POF when compared to our control group (P = 0.52) or even when compared to a large reference population (n = 1927) that did not differ significantly from our control group (P = 0.47). Our patients did have an increased frequency of HLA DR4 compared to this large reference population (41% vs. 23%; P <0.001), but we were unable to demonstrate increased HLA DR4 frequency using our control group (31%; P = 0.14). In conclusion, despite a power of 99%, we were unable to confirm a significant increase in MHC class II HLA-DR3 frequency in patients with POF.

AB - Patients with premature ovarian failure (POF) have been reported to have an increased frequency of the major histocompatibility class (MHC) class II antigen HLA-DR3. Here we attempt to confirm this association. We performed MHC class II immunophenotyping of HLA-DR antigens 1-10 on 102 North American caucasians with confirmed POF and 102 control caucasian women. All patients had experienced amenorrhea before the age of 40 yr and had elevated serum gonadotropins on repeated study. We found no significant increase in HLA-DR3 frequency in patients with POF when compared to our control group (P = 0.52) or even when compared to a large reference population (n = 1927) that did not differ significantly from our control group (P = 0.47). Our patients did have an increased frequency of HLA DR4 compared to this large reference population (41% vs. 23%; P <0.001), but we were unable to demonstrate increased HLA DR4 frequency using our control group (31%; P = 0.14). In conclusion, despite a power of 99%, we were unable to confirm a significant increase in MHC class II HLA-DR3 frequency in patients with POF.

UR - http://www.scopus.com/inward/record.url?scp=0028218573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028218573&partnerID=8YFLogxK

U2 - 10.1210/jc.78.3.722

DO - 10.1210/jc.78.3.722

M3 - Article

C2 - 8126148

AN - SCOPUS:0028218573

VL - 78

SP - 722

EP - 723

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 3

ER -